Hyperlipidemia in diabetes mellitus. (Q37934820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192855 AND SRC:MED&resulttype=core&format=json

25 September 2019

review article

1 reference

title

Hyperlipidemia in diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192855 AND SRC:MED&resulttype=core&format=json

25 September 2019

1 reference

Dunn FL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192855 AND SRC:MED&resulttype=core&format=json

25 September 2019

publication date

1 February 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192855 AND SRC:MED&resulttype=core&format=json

Diabetes/metabolism reviews

25 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192855 AND SRC:MED&resulttype=core&format=json

25 September 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192855 AND SRC:MED&resulttype=core&format=json

25 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192855 AND SRC:MED&resulttype=core&format=json

25 September 2019

page(s)

47-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2192855 AND SRC:MED&resulttype=core&format=json

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

25 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Diabetes and cardiovascular risk factors: the Framingham study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The Correlation of Arteriosclerosis Obliterans with Lipoproteins in Insulin-Dependent and Non-Insulin-Dependent Diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Coronary Heart Disease in the Pima Indians: Electrocardiographic Findings and Postmortem Evidence of Myocardial Infarction in a Population with a High Prevalence of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Comparison of plasma lipoproteins and apoproteins in Chinese and American non-insulin-dependent diabetic subjects and controls

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Serum lipids and lipoproteins in untreated diabetic children

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Plasma Lipid Levels in Diabetic Children: Effect of Diet Restricted in Cholesterol and Saturated Fats

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Diabetic lipemia. A form of acquired fat-induced lipemia

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Serum Lipids and Lipoproteins in Insulin-treated Diabetes: Demonstration of Increased High Density Lipoprotein Concentrations

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

High density lipoprotein composition in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

High density lipoprotein subfractions in insulin-dependent diabetic and normal subjects

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Haemoglobin A1, blood glucose, and high-density lipoprotein cholesterol in insulin-requiring diabetics

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Relationships between control and serum lipids in juvenile-onset diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemic control

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Hyperglycemia and plasma lipid levels: covariations in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Quantitative relationship between plasma lipids and glycohemoglobin in type I patients. Longitudinal study of 212 patients

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effect of Metabolic Control on Lipid, Lipoprotein, and Apolipoprotein Levels in 55 Insulin-dependent Diabetic Patients: A Longitudinal Study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lipid abnormalities in insulin-dependent diabetic patients with albuminuria

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Serum Lipids and Lipoproteins in Insulin-dependent Diabetic Patients with Persistent Microalbuminuria

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

A Lipid and Lipoprotein Profile of Treated and Untreated Diabetics

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lipid abnormalities in untreated maturity-onset diabetics and the effect of treatment

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Plasma lipids and diabetes mellitus in an adult community

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

A community study of high density lipoproteins in adult noninsulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Serum high density lipoprotein in diabetic patients

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lack of Awareness and Treatment of Hyperlipidemia in Type II Diabetes in a Community Survey

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in Type 2 (non-insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Changes in plasma lipoproteins accompanying diet therapy in obese diabetics

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with Type 2 (non-insulin-dependent) diabetes mellitus: a prospective study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effect of sulfonylurea therapy on plasma lipids and high-density lipoprotein composition in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Improvement of the plasma lipoprotein pattern after institution of insulin treatment in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

High-density lipoprotein subclasses in diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effect of insulin therapy on lipoproteins in non-insulin dependent diabetes mellitus (NIDDM).

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Alterations in plasma lipids in the presence of mild glucose intolerance in the offspring of two type II diabetic parents

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Influence of endogenous hyperinsulinism on high density lipoprotein2 level in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Chylomicronemia syndrome in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Early effects of anti-insulin serum on hepatic metabolism of plasma free fatty acids in dogs

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Hepatic metabolism of free fatty acids in normal and diabetic dogs

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Postheparin Plasma Lipoprotein Lipase and Hepatic Lipase in Diabetes Mellitus: Relationship to Plasma Triglyceride Metabolism

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Acute Insulin Withdrawal and the Regulation of Plasma Triglyceride Removal in Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Plasma triglyceride transport kinetics in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Treatment with artificial beta-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Presence of very low density lipoprotein compositional abnormalities in Type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cell-interactive properties

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Nonenzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glucosylation

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Interaction of human endothelial cells with elevated glucose concentrations and native and glycosylated low density lipoproteins

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Diabetic lipoprotein deficient serum: its effect in low density lipoprotein (LDL) uptake and degradation by fibroblasts

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

In Vivo Stimulation of Low-Density Lipoprotein Degradation by Insulin

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Opposite effects of insulin and catecholamines on LDL-receptor activity in human mononuclear leukocytes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Insulin-mediated increases in the HDL cholesterol/cholesterol ratio in humans

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Serum high density lipoprotein cholesterol subfractions in type I (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

High density lipoprotein subfractions during continuous insulin infusion therapy

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The effect of diabetic control on very low-density lipoprotein--triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Very low density lipoprotein metabolism in non-ketotic diabetes mellitus: effect of dietary restriction

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Very-Low-Density Lipoprotein Triglyceride Metabolism in Non-insulin-dependent Diabetes Mellitus: Relationship to Plasma Insulin and Free Fatty Acids

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Reappraisal of the role of insulin in hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Role of insulin in lipoprotein secretion by cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Abnormal lipoprotein-lipase-mediated plasma triglyceride removal in untreated diabetes mellitus associated with hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes)

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Retarded chylomicron apolipoprotein-B catabolism in type 2 (non-insulin-dependent) diabetic subjects with lipaemia

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effects of noninsulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The influence of metabolic control on very low density lipoprotein composition in hypertriglyceridemic type II diabetics. A study using heparin-sepharose chromatography

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Recommendation for strict control of plasma triglyceride in diabetic subjects

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Appearance of multidisperse low density lipoprotein and altered lipoprotein composition in non-insulin-dependent diabetes with type IIa hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Nonenzymatic glucosylation of high-density lipoprotein accelerates its catabolism in guinea pigs

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Nutritional recommendations and principles for individuals with diabetes mellitus: 1986. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Improvement of lipid status in diabetic boys: the 1971 and 1979 Joslin Camp lipid levels

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

High-carbohydrate diets and insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

The effects of a high-carbohydrate low-fat cholesterol-restricted diet on plasma lipid, lipoprotein, and apoprotein concentrations in insulin-dependent (type I) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Improved glucose control in maturity-onset diabetes treated with high-carbohydrate-modified fat diet

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effects of replacing saturated fat with complex carbohydrate in diets of subjects with NIDDM.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effect of Dietary Stearic Acid on Plasma Cholesterol and Lipoprotein Levels

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Dietary fish oils increase serum lipids in insulin-dependent diabetics compared with healthy controls

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Effect of fish oil concentrate on lipoprotein composition in NIDDM.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Hypertriglyceridemia: a contraindication to the use of bile acid binding resins

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Oral glucose tolerance, plasma insulin, and uric acid excretion in man during chronic administration of nicotinic acid

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study

1 reference

https://api.crossref.org/works/10.1002/DMR.5610060103

7 January 2021

Identifiers

DOI

10.1002/DMR.5610060103

0 references

1 reference